Toi, H., Tsujie, M., Haruta, Y., Fujita, K., Duzen, J., & Seon, B. K. (2014). Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105). Int J Cancer.
Citação norma ChicagoToi, Hirofumi, Masanori Tsujie, Yuro Haruta, Kanako Fujita, Jill Duzen, and Ben K. Seon. "Facilitation of Endoglin-targeting Cancer Therapy By Development/utilization of a Novel Genetically Engineered Mouse Model Expressing Humanized Endoglin (CD105)." Int J Cancer 2014.
Citação norma MLAToi, Hirofumi, et al. "Facilitation of Endoglin-targeting Cancer Therapy By Development/utilization of a Novel Genetically Engineered Mouse Model Expressing Humanized Endoglin (CD105)." Int J Cancer 2014.